NEWS
Life Sciences Firms Adopt Tools to Modernize Clinical Trials
The 2024 ISG Provider Lens™ global Life Sciences Digital Services report highlights a significant shift towards decentralized clinical trials in the life sciences industry. Digital technologies are enabling remote patient recruitment, monitoring, and data collection, addressing limitations of traditional centralized trials. AR and VR systems are being introduced to enhance patient participation and data visualization.
The report emphasizes the growing focus on patient-centric research and the use of AI, automation, and NLP in pharmacovigilance and regulatory compliance. Generative AI is emerging as a important tool for improving research and trials. The report also notes the increasing importance of supply chain management and collaborative
The report emphasizes the growing focus on patient-centric research and the use of AI, automation, and NLP in pharmacovigilance and regulatory compliance. Generative AI is emerging as a important tool for improving research and trials. The report also notes the increasing importance of supply chain management and collaborative
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment